Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosisCochrane Database Syst Rev 2022 May 05;5(2022)CD013444, G Filippini, S Minozzi, F Borrelli, M Cinquini, K Dwan
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.